References
- Juul S. Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models. Clin Perinatol 2004;31:129-42. https://doi.org/10.1016/j.clp.2004.03.004
- Siren AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 2001;98:4044-9. https://doi.org/10.1073/pnas.051606598
- Marti HH, Wenger RH, Rivas LA, Straumann U, Digicaylioglu M, Hehn V, et al. Erythropoietin gene expression in human monkey and murine brain. Eur J Neurosci 1996;8:666-76. https://doi.org/10.1111/j.1460-9568.1996.tb01252.x
- Wen TC, Sadamoto Y, Tanaka J. Zhu PX, Nakata K, Ma YJ, et al. Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by upregulating Bcl-xL expression. J Neurosci Res 2002;67:795-803. https://doi.org/10.1002/jnr.10166
- Koshimura K, Murakami Y, Sohmiya M, Tanaka J, Kato Y. Effects of erythropoietin on neuronal activity. J Neurochem 1999;72:2565-72. https://doi.org/10.1046/j.1471-4159.1999.0722565.x
- Calapai G, Marciano MC, Corica F, Allegra A, Parisi A, Frisina N, et al. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur J Pharmacol 2000:401:349-56. https://doi.org/10.1016/S0014-2999(00)00466-0
- Kawakami M, Sekiguchi M, Sato K, Kozaki S, Takahashi M. Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J BioI Chem 2001;276:39469-75. https://doi.org/10.1074/jbc.M105832200
- Ghezzi P, Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 2004;11:S37-44. https://doi.org/10.1038/sj.cdd.4401450
- Chakraborty M, Ghosal J, Biswas T, Datta AG. Effect of erythropoietin on membrane lipid peroxidation, superoxide dismutase, catalase and glutathione peroxidase of rat RBC. Biochem Med Metab BioI 1988:40:8-18. https://doi.org/10.1016/0885-4505(88)90099-0
- Atlason PT, Garside ML, Meddows E, Whiting P, McIlhinney RA. N-Methyl-D-aspartate (NMDA) receptor subunit NRI forms the substrate for oligomeric assembly of the NMDA receptor. J BioI Chem 2007;282:25299-307. https://doi.org/10.1074/jbc.M702778200
- Kuryatov A, Laube B, Betz H, Kuhse J. Mutational analysis of the glycine-binding site of the NMDA receptor: structural similarity with bacterial amino acid-binding proteins. Neuron 1994;12:1291-300. https://doi.org/10.1016/0896-6273(94)90445-6
- Laube B, Hirai H, Sturgess M, Betz H, Kuhse J. Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit. Neuron 1997;18:493-503. https://doi.org/10.1016/S0896-6273(00)81249-0
- Perez-Otano I, Schulteis CT, Contractor A, Lipton SA, Trimmer JS, Sucher NJ, et al. Assembly with the NRI subunit is required for surface expression of NR3A-containing NMDA receptors. J Neurosci 2001;21:1228-37.
- Dzietko M, Felderhoff-Mueser U, Sifringer M, Krutz B, Bittigau P, Thor F, et al. Erythropoietin protects the developing brain against N-methyl-d-aspartate receptor antagonist neurotoxicity. Neurobiol Dis 2004;15:177-87. https://doi.org/10.1016/j.nbd.2003.10.006
- Sinor AD, Greenberg DA. Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity. Neurosci Lett 2000;290:213-5. https://doi.org/10.1016/S0304-3940(00)01361-6
- Brewer GJ. Isolation and culture of adult rat hippocampal neurons. J Neurosci Meth 1997;71:143-55. https://doi.org/10.1016/S0165-0270(96)00136-7
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63. https://doi.org/10.1016/0022-1759(83)90303-4
- Rice JE 3rd, Vannucci RC, Brierley JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981;9:131-41. https://doi.org/10.1002/ana.410090206
- Iwai M, Cao G, Yin W, Stetler RA, Liu J, Chen J. Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats. Stroke 2007;38:2795-803. https://doi.org/10.1161/STROKEAHA.107.483008
- Vannucci RC, Perlman JM. Interventions for perinatal hypoxic-ischemic encephalopathy. Pediatrics 1997;100:1004-14. https://doi.org/10.1542/peds.100.6.1004
- Volpe JJ. Perinatal brain injury: from pathogenesis to neuroprotection. Ment Retard Dev Disabil Res Rev 2001;7:56-64. https://doi.org/10.1002/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A
- Anderson P, Doyle LW. Victorian Infant Collaborative Study Group Neurobehavioral outcomes of school-age children born extremely low birth weight or very preterm in the 1990s. JAMA 2003;289:3264-72. https://doi.org/10.1001/jama.289.24.3264
- Martin LJ. Mechanism of brain damage in animal models of hypoxia-ischemia in newborns. In: Stevenson, D.K., Benitz, W.E., Sunshine, P. (Eds), Fetal and Neonatal Brain Injury: Mechamism, management, and the Risks of Practice. Oxford University Press 2003;2:30-57.
- Ashwal S, Pearce WJ. Animal models of neonatal stroke. Curr Opin Pediatr 2001;13:506-16. https://doi.org/10.1097/00008480-200112000-00003
- Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev 1992;72:449-89.
- Marti HH, Bernaudin M, Petit E, Bauer C. Neuro-protection and angiogenesis: dual role of erythropoietin in brain ischemia. News Physiol. Sci 2000;15:225-9.
- Spandou E, Soubasi V, Papoutsopoulou S, Karkavelas G, Simeonidou C, Kaiki-Astara A, et al. Erythropoietin prevents hypoxia/ischemia-induced DNA fragmentation in an experimental model of perinatal asphyxia. Neurosci Lett 2004;366:24-8. https://doi.org/10.1016/j.neulet.2004.05.032
- Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain, eviidence from an in vitro model. J Neurosci 2002;22:10291-301.
- Grimm C, Wenzel A, Stanescu D, Samardzija M, Hotop S, Groszer M, et al. Constitutive overex-pression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci 2004;24:5651-8. https://doi.org/10.1523/JNEUROSCI.1288-04.2004
- Spandou E, Papadopoulou Z, Soubasi V, Karkavelas G, Simeonidou C, Pazaiti A, et al. Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats. Brain Res 2005;1045:22-30. https://doi.org/10.1016/j.brainres.2005.03.013
- Kim HM, Choe BH, Kwon SH, Shon YK. The effect of erythropoietin in neonatal rat model of hypoxic-ischemic brain injury. Korean J Pediatr 2009;52:105-10. https://doi.org/10.3345/kjp.2009.52.1.105
- Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp 2003;198:971-5. https://doi.org/10.1084/jem.20021067
- Naito S, Ueda T. Adenosine triphosphate-dependent uptake of glutamate into protein I-associated synaptic vesicles. J BioI Chem 1983;258:696-9.
- Dienel GA, Hertz L. Astrocytic contributions to bioenergetics of cerebral ischemia. Glia 2005;50:362-88. https://doi.org/10.1002/glia.20157
- Hestrin S. Developmental regulation of NMDA receptor-mediated synaptic currents at a central synapse. Nature 1992;357:686-9. https://doi.org/10.1038/357686a0
- Wu G, Malinow R, Cline HT. Maturation of a central glutamatergic synapse. Science 1996;274:972-6. https://doi.org/10.1126/science.274.5289.972
- Hwang JY, Kim YH, Ahn YH, Wie MB, Koh JY. N-Methyl-D-aspartate receptor blockade induces neuronal apoptosis in cortical culture. Exp Neurol 1999;159:124-30. https://doi.org/10.1006/exnr.1999.7126
- Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999;283:70-4. https://doi.org/10.1126/science.283.5398.70
- Kim SS, Lee KH, Sung DK, Shim JW, Kim MJ, Jeon GW, et al. Erythropoietin attenuates brain injury, subventricular zone expansion, and sensorimotor deficits in hypoxic-ischemic neonatal rats. J Korean Med Sci 2008;23:484-91. https://doi.org/10.3346/jkms.2008.23.3.484
- Yang SH, Shin JY, Cha SH, Park HJ, Lee KH, Lee GH, et al. The Expression of Isoforms of Nitric Oxide Synthase (NOS) and Subunits of N-methyl-D-aspartate (NMDA) Receptor according to Administration of Mycophenolic Acid before or after Perinatal Hypoxic Ischemic Brain Injury. J Korean Soc Neonatol 2007;14:1-10.